These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8899089

  • 21. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
    Albillos A, García-Pagán JC, Iborra J, Bandi JC, Cacho G, Pérez-Paramo M, Escorsell A, Calleja JL, Escartín P, Bosch J.
    Gastroenterology; 1998 Jul; 115(1):116-23. PubMed ID: 9649466
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study.
    Lafortune M, Martinet JP, Denys A, Patriquin H, Dauzat M, Dufresne MP, Colombato L, Pomier-Layrargues G.
    AJR Am J Roentgenol; 1995 Apr; 164(4):997-1002. PubMed ID: 7726065
    [Abstract] [Full Text] [Related]

  • 31. Complications of cirrhosis. I. Portal hypertension.
    Bosch J, García-Pagán JC.
    J Hepatol; 2000 Apr; 32(1 Suppl):141-56. PubMed ID: 10728801
    [Abstract] [Full Text] [Related]

  • 32. Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt.
    Brensing KA, Hörsch M, Textor J, Schiedermaier P, Raab P, Schepke M, Strunk H, Schild H, Sauerbruch T.
    Scand J Gastroenterol; 2002 Sep; 37(9):1070-6. PubMed ID: 12374234
    [Abstract] [Full Text] [Related]

  • 33. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M, Chesta J, Bosch J, Rodés J.
    Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
    [Abstract] [Full Text] [Related]

  • 34. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver.
    Cervinka J, Kordac V, Kalab M.
    J Int Med Res; 1989 Apr; 17(6):560-4. PubMed ID: 2628133
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis.
    Zoli M, Marchesini G, Brunori A, Cordiani MR, Pisi E.
    Hepatology; 1986 Apr; 6(6):1248-51. PubMed ID: 2878867
    [Abstract] [Full Text] [Related]

  • 40. Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol.
    Braillon A, Moreau R, Hadengue A, Roulot D, Sayegh R, Lebrec D.
    J Hepatol; 1989 Nov; 9(3):312-8. PubMed ID: 2607120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.